368 filings
Page 4 of 19
8-K
ATXI
Avenue Therapeutics Inc
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm
8-K
ATXI
Avenue Therapeutics Inc
21 Jul 23
Other Events
4:37pm
8-K
ATXI
Avenue Therapeutics Inc
5 Jul 23
Departure of Directors or Certain Officers
4:15pm
4
Faith L. Charles
5 Jul 23
AVENUE THERAPEUTICS / Faith L. Charles ownership change
4:10pm
4
David Jin
5 Jul 23
AVENUE THERAPEUTICS / David Jin ownership change
4:09pm
4
ATXI
Avenue Therapeutics Inc
5 Jul 23
AVENUE THERAPEUTICS / LINDSAY A MD ROSENWALD ownership change
4:08pm
4
ATXI
Avenue Therapeutics Inc
5 Jul 23
AVENUE THERAPEUTICS / JAY D KRANZLER ownership change
4:08pm
4
Curtis Gale Oltmans
5 Jul 23
AVENUE THERAPEUTICS / Curtis Gale Oltmans ownership change
4:07pm
4
ATXI
Avenue Therapeutics Inc
5 Jul 23
AVENUE THERAPEUTICS / Neil Herskowitz ownership change
4:07pm
4
Alexandra MacLean
3 Jul 23
AVENUE THERAPEUTICS / Alexandra MacLean ownership change
1:05pm
424B3
ATXI
Avenue Therapeutics Inc
28 Jun 23
Prospectus supplement
4:56pm
EFFECT
ATXI
Avenue Therapeutics Inc
28 Jun 23
Notice of effectiveness
12:15am
8-K
ATXI
Avenue Therapeutics Inc
26 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
CORRESP
ATXI
Avenue Therapeutics Inc
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
ATXI
Avenue Therapeutics Inc
22 Jun 23
Letter from SEC
12:00am
S-3
ATXI
Avenue Therapeutics Inc
Shelf registration
16 Jun 23
4:31pm
8-K
ATXI
Avenue Therapeutics Inc
22 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
10-Q
2023 Q1
ATXI
Avenue Therapeutics Inc
Quarterly report
12 May 23
4:15pm
8-K
ATXI
Avenue Therapeutics Inc
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
424B3
ATXI
Avenue Therapeutics Inc
4 May 23
Prospectus supplement
4:30pm